Blanket Purchase Agreement V797D70105-15B41420A00000001

Award Date 4/1/20
Last Date to Order 3/31/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,473,733.46, is a call under Roche's General Services Administration (GSA) Schedule 66-III for Critical Analyzers, Laboratory, and has a period of performance ending on September 30, 2024. The BPA call requires Roche...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $1,808,934.20 contract is a single-award BPA established under the GSA Schedule 66-III for Critical Analyzers, Laboratory, with a period of performance from June 2025 to June 2026. The BPA is intended to provide the VA with a...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $5.5 million, single-award BPA has an ultimate completion date of September 30, 2029 and was established under the GSA's "Critical Analyzers, Laboratory (FSS-66-III)" schedule contract. Under this BPA, Roche Diagnostics...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and related products and services. The contract, valued at over $7 million, is for the provision of chemistry analyzer tests, instruments, and supplies to support VA medical facilities in the Portland, Oregon and Castleton, Indiana regions. The...
The Department of Veterans Affairs (VA), through the Veterans Integrated Service Network 20 (VISN 20), awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) to provide chemistry analyzers and associated laboratory equipment, reagents, and services. The BPA was awarded under Roche's General Services Administration (GSA) Schedule 66-III contract for critical laboratory analyzers, with a total ceiling value of $397,419.19 and an ultimate completion date of June 30, 2024. Roche...
The Blanket Purchase Agreement (BPA) contract FA301625A0005 was awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The single-award, $4,500,000 BPA was issued by the Air Education and Training Command, a Defense agency, with a period of performance from October 1, 2024 to May 1, 2027. The BPA is intended to provide the agency with streamlined access to a variety of Roche's...
The U.S. Department of Justice Bureau of Prisons Medical Center for Federal Prisoners in Springfield, Missouri has awarded a Blanket Purchase Agreement (BPA) to Sysmex America, Inc., a U.S. subsidiary of the Japanese manufacturer and distributor Sysmex Corporation. The BPA, valued at a ceiling of $76,469.28, is for the procurement of two 6-part differential hematology analyzers, including all associated clinical materials and required service. This award is placed against Sysmex's existing...
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $1,041,901.25, allows the VA network to acquire CPRR microbiology reagents from Roche on an as-needed basis over the contract's term through September...
The Blanket Purchase Agreement (BPA) with Roche Diagnostics Corporation, valued at $3,180,000.00, was awarded by the Defense Health Agency, a defense agency, to provide a variety of medical laboratory products and services over a period of 5 years with a completion date of October 16, 2027. The BPA allows the agency to acquire chemistry and immunochemistry laboratory testing, including critical care analyzers, reagents, test kits, and associated equipment, supplies, and services on an...
The Department of Justice Bureau of Prisons Medical Center for Federal Prisoners in Springfield, Missouri has awarded a Blanket Purchase Agreement (BPA) to Biopool U.S., Inc., a subsidiary of the Ireland-based Trinity Biotech PLC, for the provision of two hemoglobin A1C analyzers, including all clinical materials and required services. The single-award BPA, which is not set aside, has a ceiling value of $199,500.00 and a period of performance through September 30, 2028. Under a $39,000.00 BPA...

This is a Blanket Purchase Agreement (BPA) awarded by the Department of Justice Bureau of Prisons Medical Center for Federal Prisoners Springfield to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide the lease and installation of chemistry and immunochemistry analyzers at the United States Medical Center for Federal Prisoners (USMCFP) in Springfield, Missouri. The contract is not set aside for any specific business type. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment, supplies, and services to various federal agencies.

The total potential value of the contract award and associated BPA calls is approximately $4.8 million, with individual call orders ranging from $79,432.21 to $238,296.63. The contract utilizes Roche's existing General Services Administration (GSA) Schedule 66-III for Critical Analyzers, Laboratory to streamline procurement of the specialized medical equipment and reagents needed to support the healthcare services at the Bureau of Prisons medical facility. Performance will primarily take place in Castleton, Indiana over multi-year ordering periods ending in 2026.

Generated 3/21/24, 9:10 AM